3D-QSAR studies of dihydropyrazole and dihydropyrrole derivatives as inhibitors of human mitotic kinesin Eg5 based on molecular docking

Molecules

Volumn 17, Issue 2, 2012, Pages 2015-2029

  Luo, Xingyan ^a   Shu, Mao ^a   Wang, Yuanqiang ^a   Liu, Jin ^a   Yang, Wenjuan ^a   Lin, Zhihua ^a  

^a CHONGQING UNIVERSITY OF TECHNOLOGY   (China)

Author keywords

3D QSAR; Eg5 inhibitors; LigandFit docking

Indexed keywords

KIF11 PROTEIN, HUMAN; KINESIN; LIGAND; PYRROLE DERIVATIVE; PYRROLINE;

ARTICLE; BINDING SITE; CHEMICAL STRUCTURE; CHEMISTRY; DRUG ANTAGONISM; DRUG EFFECT; HUMAN; MITOSIS; PROTEIN BINDING; QUANTITATIVE STRUCTURE ACTIVITY RELATION;

BINDING SITES; HUMANS; KINESIN; LIGANDS; MITOSIS; MODELS, MOLECULAR; PROTEIN BINDING; PYRROLES; QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 84863148303     PISSN: None     EISSN: 14203049     Source Type: Journal    
DOI: 10.3390/molecules17022015     Document Type: Article

References (33)

1. Blangy, A.; Lane, H.A.; d'Herin, P.; Harper, M.; Kress, M.; Nigg, E.A. Phosphorylation by p34cdc2 regulates spindle association of human Eg5, a kinesin-related motor essential for bipolar spindle formation in vivo. Cell 1995, 83, 1159-1169.
2. Weil, D.; Garcon, L.; Harper, M.; Dumenil, D.; Dautry, F.; Kress, M. Targeting the kinesin Eg5 to monitor siRNA transfection in mammalian cells. Biotechniques 2002, 33, 1244-1248. (Pubitemid 36008179)
3. Mayer, T.U.; Kapoor, T.M.; Haggarty, S.J.; King, R.W.; Schreiber, S.L.; Mitchison, T.J. Small molecule inhibitor of mitotic spindle bipolarity identified in a phenotype-based screen. Science 1999, 286, 971-974.
4. Maliga, Z.; Kapoor, T.M.; Mitchison, T.J. Evidence that monastrol is an allosteric inhibitor of the mitotic kinesin Eg5. Chem. Biol. 2002, 9, 989-996. (Pubitemid 35273719)
5. Turner, J.; Anderson, R.; Guo, J.; Beraud, C.; Fletterick, R.; Sakowicz, R. Crystal structure of the mitotic spindle kinesin Eg5 reveals a novel conformation of the neck-linker. J. Biol. Chem. 2001, 276, 25496-25502.
6. DeBonis, S.; Skoufias, D.A.; Lebeau, L.; Lopez, R.; Robin, G.; Margolis, R.L.; Wade, R.H.; Kozielski, F. In vitro screening for inhibitors of the human mitotic kinesin Eg5 with antimitotic and antitumor activities. Mol. Cancer Ther. 2004, 3, 1079-1090. (Pubitemid 39295005)
7. Skoufias, D.A.; DeBonis, S.; Saoudi, Y.; Lebeau, L.; Crevel, I.; Cross, R.; Wade, R.H.; Hackney, D.; Kozielski, F. S-trityl-L-cysteine is a reversible, tight binding inhibitor of the human kinesin Eg5 that specifically blocks mitotic progression. J. Biol. Chem. 2006, 281, 17559-17569. (Pubitemid 44035555)
8. Gartner, M.; Sunder-Plassmann, N.; Seiler, J.; Utz, M.; Vernos, I.; Surrey, T.; Giannis, A. Development and biological evaluation of potent and specific inhibitors of mitotic Kinesin Eg5. ChemBioChem 2005, 6, 1173-1177. (Pubitemid 40978175)
9. Kozielski, F.; DeBonis, S.; Skoufias, D.A. Screening for inhibitors of microtubule-associated motor proteins. Methods Mol. Med. 2007, 137, 189-207.
10. Orr, G.A.; Verdier-Pinard, P.; McDaid, H.; Horwitz, S.B. Mechanisms of Taxol resistance related to microtubules. Oncogene 2003, 22, 7280-7295. (Pubitemid 37487160)
11. Kavallaris, M. Microtubules and resistance to tubulin-binding agents. Nat. Rev. Cancer 2010, 10, 194-204.
12. Kaan, H.Y.; Weiss, J.; Menger, D.; Ulaganathan, V.; Tkocz, K.; Laggner, C.; Popowycz, F.; Joseph, B.; Kozielski, F. Structure-activity relationship and multidrug resistance study of new S-trityl-L-cysteine derivatives as inhibitors of Eg5. J. Med. Chem. 2011, 54, 1576-1586.
13. Barsanti, P.A.; Wang, W.; Ni, Z.-J.; Duhl, D.; Brammeier, N.; Martin, E.; Bussiere, D.; Walter, A.O. The discovery of tetrahydro-β-carbolines as inhibitors of the kinesin Eg5. Bioorg. Med. Chem. Lett. 2010, 20, 157-160.
14. Liu, M.; Yu, H.; Huo, L.; Liu, J.; Li, M.; Zhou, J. Validating the mitotic kinesin Eg5 as a therapeutic target in pancreatic cancer cells and tumor xenografts using a specific inhibitor. Biochem. Pharmacol. 2008, 76, 169-178.
15. Xiao, S.; Shi, X.-X. The first highly stereoselective approach to the mitotic kinesin Eg5 inhibitor HR22C16 and its analogues. Tetrahedron: Asymmetry 2010, 21, 226-231.
16. Cox, C.D.; Torrent, M.; Breslin, M.J.; Mariano, B.J.; Whitman, D.B.; Coleman, P.J.; Buser, C.A.; Walsh, E.S.; Hamilton, K.; Schaber, M.D. Kinesin spindle protein (KSP) inhibitors. Part 4:1 Structure-based design of 5-alkylamino-3,5-diaryl-4,5-dihydropyrazoles as potent, water-soluble inhibitors of the mitotic kinesin KSP. Bioorg. Med. Chem. Lett. 2006, 16, 3175-3179.
17. Fraley, M.E.; Garbaccio, R.M.; Arrington, K.L.; Hoffman, W.F.; Tasber, E.S.; Coleman, P.J.; Buser, C.A.; Walsh, E.S.; Hamilton, K.; Fernandes, C. Kinesin spindle protein (KSP) inhibitors. Part 2: The design, synthesis, and characterization of 2,4-diaryl-2,5-dihydropyrrole inhibitors of the mitotic kinesin KSP. Bioorg. Med. Chem. Lett. 2006, 16, 1775-1779. (Pubitemid 43267348)
18. Roecker, A.J.; Coleman, P.J.; Mercer, S.P.; Schreier, J.D.; Buser, C.A.; Walsh, E.S.; Hamilton, K.; Lobell, R.B.; Tao, W.; Diehl, R.E. Kinesin spindle protein (KSP) inhibitors. Part 8: Design and synthesis of 1,4-diaryl-4,5- dihydropyrazoles as potent inhibitors of the mitotic kinesin KSP. Bioorg. Med. Chem. Lett. 2007, 17, 5677-5682. (Pubitemid 47391301)
19. Brier, S.; Lemaire, D.; Debonis, S.; Forest, E.; Kozielski, F. Identification of the protein binding region of S-trityl-L-cysteine, a new potent inhibitor of the mitotic kinesin Eg5. Biochemistry 2004, 43, 13072-13082. (Pubitemid 39362777)
20. Yi Kristal Kaan, H.; Ulaganathan, V.; Hackney, D.D.; Kozielski, F. An allosteric transition trapped in an intermediate state of a new kinesin-inhibitor complex. Biochem. J. 2010, 425, 55-60.
21. Debonis, S.; Skoufias, D.A.; Indorato, R.L.; Liger, F.; Marquet, B.; Laggner, C.; Joseph, B.; Kozielski, F. Structure-activity relationship of S-trityl-L-cysteine analogues as inhibitors of the human mitotic kinesin Eg5. J. Med. Chem. 2008, 51, 1115-1125. (Pubitemid 351480375)
22. Kozielski, F.; Skoufias, D.A.; Indorato, R.L.; Saoudi, Y.; Jungblut, P.R.; Hustoft, H.K.; Strozynski, M.; Thiede, B. Proteome analysis of apoptosis signaling by S-trityl-L-cysteine, a potent reversible inhibitor of human mitotic kinesin Eg5. Proteomics 2008, 8, 289-300. (Pubitemid 351212328)
23. Prokopcova, H.; Dallinger, D.; Uray, G.; Kaan, H.Y.; Ulaganathan, V.; Kozielski, F.; Laggner, C.; Kappe, C.O. Structure-activity relationships and molecular docking of novel dihydropyrimidine-based mitotic Eg5 inhibitors. ChemMedChem 2010, 5, 1760-1769.
24. Kubinyi, H. QSAR and 3D QSAR in drug design Part 1: Methodology. Drug Discov. Today 1997, 2, 457-467. (Pubitemid 27450428)
25. Cramer, R.D.; Patterson, D.E.; Bunce, J.D. Comparative molecular field analysis (CoMFA). 1. Effect of shape on binding of steroids to carrier proteins. J. Am. Chem. Soc. 1988, 110, 5959-5967.
26. Klebe, G.; Abraham, U.; Mietzner, T. Molecular similarity indices in a comparative analysis (CoMSIA) of drug molecules to correlate and predict their biological activity. J. Med. Chem. 1994, 37, 4130-4146. (Pubitemid 24379702)
27. Puntambekar, D.; Giridhar, R.; Yadav, M.R. 3D-QSAR studies of farnesyltransferase inhibitors: A comparative molecular field analysis approach. Bioorg. Med. Chem. Lett. 2006, 16, 1821-1827. (Pubitemid 43267358)
28. Zhang, H.; Liu, C.; Li, H. CoMFA and CoMSIA Studies of nAChRs Ligands: Epibatidine Analogues. QSAR Comb. Sci. 2004, 23, 80-88. (Pubitemid 39486051)
29. Zhang, Q.; Yu, C.; Min, J.; Wang, Y.; He, J.; Yu, Z. Rational questing for potential novel inhibitors of FabK from Streptococcus pneumoniae by combining FMO calculation, CoMFA 3D-QSAR modeling and virtual screening. J. Mol. Model. 2010, 17, 1483-1492.
30. AbdulHameed, M.D.; Hamza, A.; Liu, J.; Huang, X.; Zhan, C.G. Human microsomal prostaglandin E synthase-1 (mPGES-1) binding with inhibitors and the quantitative structure-activity correlation. J. Chem. Inf. Model. 2008, 48, 179-185. (Pubitemid 351271063)
31. Venkatachalam, C.M.; Jiang, X.; Oldfield, T.; Waldman, M. LigandFit: A novel method for the shape-directed rapid docking of ligands to protein active sites. J. Mol. Graph. Model. 2003, 21, 289-307. (Pubitemid 35441326)
32. Sippl, W. Application of Structure-Based Alignment Methods for 3D QSAR Analyses. In Pharmacophores and Pharmacophore Searches; Wiley-VCH Verlag GmbH & Co. KGaA: Weinheim, Germany, 2006; pp. 223-249.
33. Liu, T.; Lin, Y.; Wen, X.; Jorissen, R.N.; Gilson, M.K. BindingDB: A web-accessible database of experimentally determined protein-ligand binding affinities. Nucleic Acids Res. 2007, 35, D198-D201. (Pubitemid 46056198)